Nanomaterials and neurodegeneration

Environmental and Molecular Mutagenesis

Volumn 56, Issue 2, 2015, Pages 149-170

  Migliore, Lucia ^a   Uboldi, Chiara ^a   Di Bucchianico, Sebastiano ^a   Coppedè, Fabio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Nanodevices; Nanomaterials; Nanoparticles; Neurodegenerative diseases; Neurotoxicity; Oxidative stress

Indexed keywords

BETA TUBULIN; CARBON NANOTUBE; COPPER NANOPARTICLE; COPPER OXIDE NANOPARTICLE; F ACTIN; GLUTATHIONE; LACTATE DEHYDROGENASE; MAGNETIC NANOPARTICLE; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MULTI WALLED NANOTUBE; NANOMATERIAL; SILICA NANOPARTICLE; SILVER NANOPARTICLE; SUPEROXIDE DISMUTASE; TITANIUM DIOXIDE; TITANIUM DIOXIDE NANOPARTICLE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE; METAL NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; TITANIUM; ZINC OXIDE;

BLOOD BRAIN BARRIER; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM; CYTOTOXICITY; GENOTOXICITY; HUMAN; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION; REVIEW; DRUG EFFECTS; METABOLISM; PARTICLE SIZE;

RODENTIA;

CENTRAL NERVOUS SYSTEM; HUMANS; METAL NANOPARTICLES; NANOTUBES, CARBON; OXIDATIVE STRESS; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SILICON DIOXIDE; TITANIUM; ZINC OXIDE;

EID: 84925342593     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21931     Document Type: Review

References (163)

1. Agyare EK, Jaruszewski KM, Curran GL, Rosenberg JT, Grant SC, Lowe VJ, Ramakrishnan S, Paravastu AK, Poduslo JF, Kandimalla KK. 2014. Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits. J Control Release 185:121-129.
2. Ahamed M. 2013. Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells. Hum Exp Toxicol 32:186-195.
3. Ahmad J, Ahamed M, Akhtar MJ, Alrokayan SA, Siddiqui MA, Musarrat J, Al-Khedhairy AA. 2012. Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2. Toxicol Appl Pharmacol 259:160-168.
4. Akhtar MJ, Ahamed M, Kumar S, Siddiqui H, Patil G, Ashquin M, Ahmad I. 2010. Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. Toxicology 276:95-102.
5. Amiri H, Saeidi K, Borhani P, Manafirad A, Ghavami M, Zerbi V. 2013. Alzheimer's disease: Pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents. ACS Chem Neurosci 4:1417-1429.
6. Amor S, Peferoen LA, Vogel DY, Breur M, van der Valk P, Baker D, van Noort JM. 2014. Inflammation in neurodegenerative diseases-an update. Immunology 142:151-166.
7. An L, Liu S, Yang Z, Zhang T. 2012 Cognitive impairment in rats induced by nano-CuO and its possible mechanisms. Toxicol Lett 3;213:220-227.
8. Au C, Mutkus L, Dobson A, Riffle J, Lalli J, Aschner M. 2007. Effects of nanoparticles on the adhesion and cell viability on astrocytes. Biol Trace Elem Res 120:248-256.
9. Avti PK, Talukdar Y, Sirotkin MV, Shroyer KR, Sitharaman B. 2013. Toward single-walled carbon nanotube-gadolinium complex as advanced MRI contrast agents: Pharmacodynamics and global genomic response in small animals. J Biomed Mater Res Part B 101B:1039-1049.
10. Bardi G, Nunes A, Gherardini L, Bates K, Al-Jamal KT, Gaillard C, Prato M, Bianco A, Pizzorusso T, Kostarelos K. 2013. Functionalized carbon nanotubes in the brain: Cellular internalization and neuroinflammatory responses. PLoS One 8:e80964.
11. Bäumer D, Talbot K, Turner MR. 2014. Advances in motor neurone disease. J R Soc Med 107:14-21.
12. Behan N, Birkinshaw C, Clarke N. 2001. Poly-nbutyl cyanoacrylate nanoparticles: A mechanistic study of polymerization and particle formation. Biomaterials 22:1335-1344.
13. Belyanskaya L, Weigel S, Hirsch C, Tobler U, Krug HF, Wick P. 2009. Effects of carbon nanotubes on primary neurons and glial cells. Neurotoxicology 30:702-711.
14. Brasnjevic I, Steinbusch HW, Schmitz C, Martinez-Martinez P. 2009. European NanoBioPharmaceutics Research Initiative. Delivery of peptide and protein drugs over the blood-brain barrier. Prog Neurobiol 87:212-251.
15. Brown DM, Kanase N, Gaiser B, Johnston H, Stone V. 2014. Inflammation and gene expression in the rat lung after instillation of silica nanoparticles: Effect of size, dispersion medium and particle surface charge. Toxicol Lett 224:147-156.
16. Carpenter DO. 2001. Effects of metals on the nervous system of humans and animals. Int J Occup Med Environ Health 14:209-218.
17. Chiu S, Terpstra KJ, Bureau Y, Hou J, Raheb H, Cernvosky Z, Badmeav V, Copen J, Husni M, Woodbury-Farina M. 2013. Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: Implications for epigenetics-based nanotechnology-driven drug platform. J Complement Integr Med 10:75-88.
18. Cho WS, Kang BC, Lee JK, Jeong J, Che JH, Seok SH. 2013. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol 10:9.
19. Choi M, Cho WS, Han BS, Cho M, Kim SY, Yi JY, Ahn B, Kim SH, Jeong J. 2008. Transient pulmonary fibrogenic effect induced by intratracheal instillation of ultrafine amorphous silica in A/J mice. Toxicol Lett 182:97-101.
20. Choi J, Zheng Q, Katz HE, Guilart, TR. 2010. Silica-based nanoparticle uptake and cellular response by primary microglia. Environ Health Perspect 118:589-595.
21. Coccini T, Manzo L, Bellotti V, De Simone U. 2014. Assessment of cellular responses after short- and long-term exposure to silver nanoparticles in human neuroblastoma (SH-SY5Y) and astrocytoma (D384) cells. Sci World J 2014:259765.
22. Coppedè F, Migliore L. 2010. DNA repair in premature aging disorders and neurodegeneration. Curr Aging Sci 3:3-19.
23. Cupaioli FA, Zucca FA, Boraschi D, Zecca L. 2014. Engineered nanoparticles. How brain friendly is this new guest?. Prog Neurobiol 119-120:20-38.
24. de Oliveira GM, Kist LW, Pereira TC, Bortolotto JW, Paquete FL, de Oliveira EM, Leite CE, Bonan CD, de Souza Basso NR, Papaleo RM, Bogo MR. 2014. Transient modulation of acetylcholinesterase activity caused by exposure to dextran-coated iron oxide nanoparticles in brain of adult zebrafish. Comp Biochem Physiol C Toxicol Pharmacol 162:77-84.
25. Deng X, Luan Q, Chen W, Wang Y, Wu M, Zhang H, Jiao Z. 2009. Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology 20:115101.
26. Desai V, Kaler SG. 2008. Role of copper in human neurological disorders. Am J Clin Nutr 88:855S-858S.
27. Dringen R, Bishop GM, Koeppe M, Dang TN, Robinson SR. 2007. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res 32:1884-1890.
28. Dziendzikowska K, Gromadzka-Ostrowska J, Lankoff A, Oczkowski M, Krawczyńska A, Chwastowska J, Sadowska-Bratek M, Chajduk E, Wojewódzka M, Dušinská M, Kruszewski M. 2012. Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J Appl Toxicol 32:920-928.
29. Eom HJ, Choi J. 2009. Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B. Toxicol In Vitro 23:1326-1332.
30. Garbayo E, Ansorena E, Blanco-Prieto MJ. 2013. Drug development in Parkinson's disease: From emerging molecules to innovative drug delivery systems. Maturitas 76:272-278.
31. Genter MB, Newman NC, Shertzer HG, Ali SF, Bolon B. 2012. Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicol Pathol 40:1004-1013.
32. Geppert M, Hohnholt M, Gaetjen L, Grunwald I, Baümer M, Dringen R. 2009. Accumulation of iron oxide nanoparticles by cultured brain astrocytes. J Biomed Nanotechnol 5:285-293.
33. Geppert M, Hohnholt MC, Thiel K, Nurnberger S, Grunwald I, Rezwan K, Dringen R. 2011. Uptake of dimercaptosuccinatecoated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 22:145101.
34. Geppert M, Hohnholt MC, Nürnberger S, Dringen R. 2012. Ferritin up-regulation and transient production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater 8:3832-3839.
35. Giordano S, Darley-Usmar V, Zhang J. 2013. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease. Redox Biol 2:82-90.
36. Golde TE, Borchelt DR, Giasson BI, Lewis J. 2013. Thinking laterally about neurodegenerative proteinopathies. J Clin Invest 123:1847-1855.
37. Greenough MA, Camakaris J, Bush AI. 2013. Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem Int 62:540-555.
38. Hadrup N, Loeschner K, Mortensen A, Sharma AK, Qvortrup K, Larsen EH, Lam HR. 2012. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. Neurotoxicology 33:416-423.
39. Halliwell B, Gutteridge JM. 1984. Oxygen toxicity, oxygen radicals, transition metals and diseases. Biochem J 219:1-14.
40. Hamilton RF, Buckingham S, Holian A. 2014. The effect of size on Ag nanosphere toxicity in macrophage cell models and lung epithelial cell lines is dependent on particle dissolution. Int J Mol Sci 15:6815-6830.
41. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356.
42. Hernández-Ferrer J, Pérez-Bruzón RN, Azanza MJ, González M, Del Moral R, Ansón-Casaos A, de la Fuente JM, Marijuan PC, Martínez MT. 2014. Study of neuron survival on polypyrrole-embedded single-walled carbon nanotube substrates for long term growth conditions. J Biomed Mater Res A 102:4443-4454.
43. Hirrlinger J, Dringen R. 2010. The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev 63:177-188.
44. Hohnholt M, Geppert M, Dringen R. 2010. Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells. Neurochem Res 35:1259-1268.
45. Hohnholt MC, Geppert M, Luther EM, Petters C, Bulcke F, Dringen R. 2013. Handling of iron oxide and silver nanoparticles by astrocytes. Neurochem Res 38:227-239.
46. Hu K, Shi Y, Jiang W, Han J, Huang S, Jiang X. 2011. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease. Int J Pharm 415:273-283.
47. Huang R, Han L, Li J, Ren F, Ke W, Jiang C, Pei Y. 2009. Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles. J Gene Med 11:754-763.
48. Huang X, Zhang F, Sun X, Choi KY, Niu G, Zhang G, Guo J, Lee S, Chen X. 2014. The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development. Biomaterials 35:856-865.
49. Huerta-García E, Pérez-Arizti JA, Márquez-Ramírez SG, Delgado-Buenrostro NL, Chirino YI, Iglesias GG, López-Marure R. 2014. Titanium dioxide nanoparticles induce strong oxidative stress and mitochondrial damage in glial cells. Free Radic Biol Med 73C:84-94.
50. Iqbal A, Ahmad I, Khalid MH, Nawaz MS, Gan SH, Kamal MA. 2013. Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 31:256-284.
51. Ismail MF, Elmeshad AN, Salem NA. 2013. Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease. Int J Nanomed 8:393-406.
52. Ito A, Shinkai M, Honda H, Kobayashi T. 2005. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100:1-11.
53. Jaruszewski KM, Curran GL, Swaminathan SK, Rosenberg JT, Grant SC, Ramakrishnan S, Lowe VJ, Poduslo JF, Kandimalla KK. 2014. Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain. Biomaterials 35:1967-1976.
54. Ji SL, Ye CH. 2008. Effect of complexing agents on properties of electroless Ni-P deposits. J Mater Sci Technol 24:457-460.
55. Jones CE. 2012 The emerging role of astrocytes in the metal homeostasis in brain. Global J Inorg Chem 3:4.
56. Kao YY, Cheng TJ, Yang DM, Wang CT, Chiung YM, Liu PS. 2012. Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. J Mol Neurosci 48:464-471.
57. Kim JS, Yoon TJ, Yu KN, Kim BG, Park SJ, Kim HW, Lee KH, Park SB, Lee JK, Cho MH. 2006. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 89:338-347.
58. Kim Y, Kong SD, Chen LH, Pisanic TR 2nd, Jin S, Shubayev VI. 2013. In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms. Nanomedicine 9:1057-1066.
59. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, et al. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20:575-583.
60. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, Kelman BJ, et al. 2010. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 7:20.
61. Kodama H, Fujisawa C, Bhadhprasit W. 2011. Pathology, clinical features and treatments of congenital copper metabolic disorders-focus on neurologic aspects. Brain Dev 33:243-251.
62. Kreuter J. 2004. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol 4:484-488.
63. Kusaka T, Nakayama M, Nakamura K, Ishimiya M, Furusawa E, Ogasawara K. 2014. Effect of silica particle size on macrophage inflammatory responses. PLoS One 9:e92634.
64. Kwon JT, Hwang SK, Jin H, Kim DS, Minai-Tehrani A, Yoon HJ, Choi M, Yoon TJ, Han DY, Kang YW, et al. 2008. Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health 50:1-6.
65. Lai JC, Lai MB, Jandhyam S, Dukhande VV, Bhushan A, Daniels CK, Leung SW. 2008. Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts. Int J Nanomed 3:533-545.
66. Lamkowsky MC, Geppert M, Schmidt MM, Dringen R. 2012. Magnetic field-induced acceleration of the accumulation of magnetic iron oxide nanoparticles by cultured brain astrocytes. J Biomed Mater Res A 100A:323-334.
67. Lazar AN, Mourtas S, Youssef I, Parizot C, Dauphin A, Delatour B, Antimisiaris SG, Duyckaerts C. 2013. Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease. Nanomedicine 9:712-721.
68. Lee S, Yun HS, Kim SH. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 32:9434-9443.
69. Li X, Liu B, Li XL, Li YX, Sun MZ, Chen DY, Zhao X, Feng XZ. 2014. SiO2 nanoparticles change colour preference and cause Parkinson's-like behaviour in zebrafish. Sci Rep 4:3810.
70. Liu X, Sun J. 2010. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kB pathways. Biomaterials 31:8198-8209.
71. Liu D, Lin B, Shao W, Zhu Z, Ji T, Yang C. 2014. In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier. ACS Appl Mater Interf 6:2131-2136.
72. Liu T, Li L, Fu C, Liu H, Chen D, Tang F. 2012. Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles. Biomaterials 33:2399-2407.
73. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, Mortensen A, Lam HR, Larsen EH. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18.
74. Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B. 2006. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): Implications for nanoparticle neurotoxicity. Environ Sci Technol 40:4346-4352.
75. Lorincz MT. 2010. Neurologic Wilson's disease. Ann N Y Acad Sci 1184:173-187.
76. Macco R, Pelizzoni I, Consonni A, Vitali I, Giacalone G, Martinelli Boneschi F, Codazzi F, Grohovaz F, Zacchetti D. 2013. Astrocytes acquire resistance to iron-dependent oxidative stress upon proinflammatory activation. J Neuroinflammation 10:130.
77. Márquez-Ramírez SG, Delgado-Buenrostro NL, Chirino YI, Iglesias GG, López-Marure R. 2012. Titanium dioxide nanoparticles inhibit proliferation and induce morphological changes and apoptosis in glial cells. Toxicology 302:146-156.
78. Marrache S, Pathak RK, Darley KL, Choi JH, Zaver D, Kolishetti N, Dhar S. 2013. Nanocarriers for tracking and treating diseases. Curr Med Chem 20:3500-3514.
79. Mendoza A, Torres-Hernandez JA, Ault JG, Pedersen-Lane JH, Gao D, Lawrence DA. 2014. Silica nanoparticles induce oxidative stress and inflammation of human peripheral blood mononuclear cells. Cell Stress Chaperones 19:777-790.
80. Meng L, Jiang A, Chen R, Li CZ, Wang L, Qu Y, Wang P, Zhao Y, Chen C. 2013. Inhibitory effects of multiwall carbon nanotubes with high iron impurity on viability and neuronal differentiation in cultured PC12 cells. Toxicology 313:49-58.
81. Mercer RR, Scabilloni JF, Hubbs AF, Wang L, Battelli LA, McKinney W, Castranova V, Porter DW. 2013. Extrapulmonary transport of MWCNT following inhalation exposure. Part Fibre Toxicol 10:38.
82. Migliore L, Coppedè F. 2009. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res 667:82-97.
83. Mittal G, Carswell H, Brett R, Currie S, Kumar MN. 2011. Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology. J Control Release 150:220-228.
84. Modi G, Pillay V, Choonara YE, Ndesendo VM, du Toit LC, Naidoo D. 2009. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol 88:272-285.
85. Modi G, Pillay V, Choonara YE. 2010. Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann N Y Acad Sci 1184:154-172.
86. Mohammadipour A, Fazel A, Haghir H, Motejaded F, Rafatpanah H, Zabihi H, Hosseini M, Bideskan AE. 2014. Maternal exposure to titanium dioxide nanoparticles during pregnancy; impaired memory and decreased hippocampal cell proliferation in rat offspring. Environ Toxicol Pharmacol 37:617-625.
87. Montes S, Rivera-Mancia S, Diaz-Ruiz A, Tristan-Lopez L, Rios C. Copper and copper proteins in Parkinson's disease. Oxid Med Cell Longev 2014:147251.
88. Morales-Narváez E, Montón H, Fomicheva A, Merkoçi A. 2012. Signal enhancement in antibody microarrays using quantum dots nanocrystals: Application to potential Alzheimer's disease biomarker screening. Anal Chem 84:6821-6827.
89. Morishige T, Yoshioka Y, Inakura H, Tanabe A, Narimatsu S, Yao X, Monobe Y, Imazawa T, Tsunoda S, Tsutsumi Y, et al. 2012. Suppression of nanosilica particle-induced inflammation by surface modification of the particles. Arch Toxicol 86:1297-1307.
90. Mourtas S, Canovi M, Zona C, Aurilia D, Niarakis A, La Ferla B, Salmona M, Nicotra F, Gobbi M, Antimisiaris SG. 2011. Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide. Biomaterials 32:1635-1645.
91. Napierska D, Thomassen LC, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Martens JA, Hoet PH. 2009. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5:846-853.
92. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K. 2009. Silica nanoparticles as hepatotoxicants. Eur J Pharm Biopharm 72:496-501.
93. Ntim SA, Sae-Khow O, Desai C, Witzmann FA, Mitra S. 2012. Size dependent aqueous dispersibility of carboxylated multiwall carbon nanotubes. J Environ Monit 14:2772-2779.
94. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. 2004. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437-445.
95. Oesterling BM, Gulati A, Joshi MD. 2014. Nanocarrier-based approaches for treatment and detection of Alzheimer's disease. J Nanosci Nanotechnol 14:137-156.
96. Oomen AG, Bos PM, Fernandes TF, Hund-Rinke K, Boraschi D, Byrne HJ, Aschberger K, Gottardo S, von der Kammer F, Kühnel D, et al. 2014. Concern-driven integrated approaches to nanomaterial testing and assessment-report of the NanoSafety Cluster Working Group 10. Nanotoxicology 8:334-348.
97. Panas A, Marquardt C, Nalcaci O, Bockhorn H, Baumann W, Paur HR, Mülhopt S, Diabaté S, Weiss C. 2013. Screening of different metal oxide nanoparticles reveals selective toxicity and inflammatory potential of silica nanoparticles in lung epithelial cells and macrophages. Nanotoxicology 7:259-273.
98. Panyala NR, Peña-Méndez EM, Havel J. 2008. Silver or silver nanoparticles: A hazardous threat to the environment and human health?. J Appl Biomed 6:117-129.
99. Park EJ, Park K. 2009. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett 184:18-25.
100. Park EJ, Bae E, Yi J, Kim Y, Choi K, Lee SH, Yoon J, Lee BC, Park K. 2010. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 30:162-168.
101. Petters C, Irrsack E, Koch M, Dringen R. 2014. Uptake and metabolism of iron oxide nanoparticles in brain cells. Neurochem Res 39:1648-1660.
102. Pisanic TR 2nd, Blackwell JD, Shubayev VI, Fiñones RR, Jin S. 2007. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 28:2572-2581.
103. Poduslo JF, Hultman KL, Curran GL, Preboske GM, Chamberlain R, Marjańska M, Garwood M, Jack CR Jr, Wengenack TM. 2011. Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid β protein antibody-coated nanoparticles. J Neuropathol Exp Neurol 70:653-661.
104. Radniecki TS, Stankus DP, Neigh A, Nason JA, Semprini L. 2011. Influence of liberated silver from silver nanoparticles on nitrification inhibition of Nitrosomonas europaea. Chemosphere 85:43-49.
105. Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Newport GD, Murdock RC, Schlager JJ, Hussain SM, Ali SF. 2009. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 187:15-21.
106. Ramanan VK, Saykin AJ. 2013. Pathways to neurodegeneration: Mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis 2:145-175.
107. Redzic Z. 2011. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: Similarities and differences. Fluids Barriers CNS 8:3.
108. Rivera-Mancía S, Pérez-Neri I, Ríos C, Tristán-López L, Rivera-Espinosa L, Montes S. 2010. The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact 186:184-199.
109. Robertson TA, Sanchez WY, Roberts MS. 2010. Are commercially available nanoparticles safe when applied to the skin? J Biomed Nanotechnol 6:452-468.
110. Rocha S. 2013. Targeted drug delivery across the blood brain barrier in Alzheimer's disease. Curr Pharm Des 19:6635-6646.
111. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
112. Schröfel A, Kratošová G, Safařík I, Safaříková M, Raška I, Shor LM. 2014. Applications of biosynthesized metallic nanoparticles - A review. Acta Biomater 10:4023-4042.
113. Shannahan JH, Kodavanti UP, Brown JM. 2012. Manufactured and airborne nanoparticle cardiopulmonary interactions: A review of mechanisms and the possible contribution of mast cells. Inhal Toxicol 24:320-339.
114. Sharma HS, Sharma A. 2007. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog Brain Res 162:245-273.
115. Sharma HS, Ali SF, Hussain SM, Schlager JJ, Sharma A. 2009. Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J Nanosci Nanotechnol 9:5055-5072.
116. Sharma HS, Hussain S, Schlager J, Ali SF, Sharma A. 2010. Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta Neurochir Suppl 106:359-364.
117. Sharma HS, Muresanu DF, Patnaik R, Sharma A. 2013a. Exacerbation of brain pathology after partial restraint in hypertensive rats following SiO2 nanoparticles exposure at high ambient temperature. Mol Neurobiol 48:368-379.
118. Sharma A, Muresanu DF, Patnaik R, Sharma HS. 2013b. Size- and age-dependent neurotoxicity of engineered metal nanoparticles in rats. Mol Neurobiol 48:386-396.
119. Shrivastava R, Raza S, Yadav A, Kushwaha P, Flora SJ. 2014. Effects of sub-acute exposure to TiO2, ZnO and Al2O3 nanoparticles on oxidative stress and histological changes in mouse liver and brain. Drug Chem Toxicol 37:336-347.
120. Singh RP, Ramarao P. 2010. Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicol Lett 213:249-259.
121. Song KS, Sung JH, Ji JH, Lee JH, Lee JS, Ryu HR, Lee JK, Chung YH, Park HM, Shin BS, et al. 2013. Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats. Nanotoxicology 7:169-180.
122. Stoccoro A, Karlsson HL, Coppedè F, Migliore L. 2013. Epigenetic effects of nano-sized materials. Toxicology 313:3-14.
123. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, et al. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452-461.
124. Tang J, Xiong L, Zhou G, Wang S, Wang J, Liu L, Li J, Yuan F, Lu S, Wan Z, et al. 2010. Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J Nanosci Nanotechnol 10:6313-6317.
125. Taylor M, Moore S, Mourtas S, Niarakis A, Re F, Zona C, La Ferla B, Nicotra F, Masserini M, Antimisiaris SG, Gregori M, Allsop D. 2011. Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide. Nanomedicine 7:541-550.
126. Thomas B, Beal MF. 2011. Molecular insights into Parkinson's disease. F1000 Med Rep 3:7.
127. Tiffany-Castiglioni E, Qian Y. 2001. Astroglia as metal depots: Molecular mechanisms for metal accumulation, storage and release. Neurotoxicology 22:577-592.
128. Trickler WJ, Lantz SM, Murdock RC, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Oldenburg SJ, Paule MG, Slikker W Jr, et al. 2010. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci 118:160-170.
129. Trickler WJ, Lantz SM, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Paule MG, Slikker W, Biris AS, Hussain SM, Ali SF. 2012. Effects of copper nanoparticles on rat cerebral microvessel endothelial cells. Nanomedicine (Lond) 7:835-846.
130. Trickler WJ, Lantz-McPeak SM, Robinson BL, Paule MG, Slikker W Jr, Biris AS, Schlager JJ, Hussain SM, Kanungo J, Gonzalez C, Ali SF. 2014. Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles. Drug Metab Rev 46:224-231.
131. Valdiglesias V, Costa C, Kiliç G, Costa S, Pásaro E, Laffon B, Teixeira JP. 2013a. Cytotoxicity and genotoxicity induced by zinc oxide nanoparticles. Environ Int 55:92-100.
132. Valdiglesias V, Costa C, Sharma V, Kiliç G, Pásaro E, Teixeira JP, Dhawan A, Laffon B. 2013b. Comparative study on effects of two different types of titanium dioxide nanoparticles on human neuronal cells. Food Chem Toxicol 57:352-361.
133. Valdiglesias V, Kiliç G, Costa C, Fernández-Bertólez N, Pásaro E, Teixeira JP, Laffon B. 2014. Effects of iron oxide nanoparticles: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity. Environ Mol Mutagen (in press). doi:10.1002/em.21909. [Epub ahead of print]
134. Vandebriel RJ, De Jong WH. 2012. A review of mammalian toxicity of ZnO nanoparticles. Nanotechnol Sci Appl 5:61-71.
135. van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, Gremmer ER, Mast J, Peters RJ, et al. 2012. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6:7427-7442.
136. Vanderweyde T, Youmans K, Liu-Yesucevitz L, Wolozin B. 2013. Role of stress granules and RNA-binding proteins in neurodegeneration: A mini-review. Gerontology 59:524-533.
137. Visnapuu M, Joost U, Juganson K, Künnis-Beres K, Kahru A, Kisand V, Ivask A. 2013. Dissolution of silver nanowires and nanospheres dictates their toxicity to Escherichia coli. Biomed Res Int 2013:819252.
138. Wang J, Chen Y, Chen B, Ding J, Xia G, Gao C, Cheng J, Jin N, Zhou Y, Li X, et al. 2010. Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice. Int J Nanomed 5:861-866.
139. Wang J, Liu Y, Jiao F, Lao F, Li W, Gu Y, Li Y, Ge C, Zhou G, Li B, et al. 2008. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicology 254:82-90.
140. Wang J, Rahman MF, Duhart HM, Newport GD, Patterson TA, Murdock RC, Hussain SM, Schlager JJ, Ali SF. 2009. Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 30:926-933.
141. Wang F, Jiao C, Liu J, Yuan H, Lan M, Gao F. 2011a. Oxidative mechanisms contribute to nanosize silican dioxide-induced developmental neurotoxicity in PC12 cells. Toxicol In Vitro 25:1548-1556.
142. Wang J, Sun P, Bao Y, Liu J, An L. 2011b. Cytotoxicity of single-walled carbon nanotubes on PC12 cells. Toxicol In Vitro 25:242-250.
143. Wang J, Sun P, Bao Y, Dou B, Song D, Li Y. 2012. Vitamin E renders protection to PC12 cells against oxidative damage and apoptosis induced by single-walled carbon nanotubes. Toxicol In Vitro 26:32-41.
144. Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B. 2008. Poly (n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res 1200:159-168.
145. Wolburg H, Lippoldt A. 2002. Tight junctions of the blood-brain barrier: Development, composition and regulation. Vascul Pharmacol 38:323-337.
146. Wu J, Sun J, Xue Y. 2010. Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells. Toxicol Lett 199:269-276.
147. Wu J, Wang C, Sun J, Xue Y. 2011. Neurotoxicity of silica nanoparticles: Brain localization and dopaminergic neurons damage pathways. ACS Nano 5:4476-4489.
148. Wu J, Ding T, Sun J. 2013. Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology 34:243-253.
149. Xie Y, Wang Y, Zhang T, Ren G, Yang Z. 2012. Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors. J Biomed Sci 19:14.
150. Xu F, Piett C, Farkas S, Qazzaz M, Syed NI. 2013. Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons. Mol Brain 6:29.
151. Xue Y, Wu J, Sun J. 2012. Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro. Toxicol Lett 214:91-98.
152. Yang Z, Zhang Y, Yang Y, Sun L, Han D, Li H, Wang C. 2010. Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease. Nanomedicine 6:427-441.
153. Yang J, Wadghiri YZ, Hoang DM, Tsui W, Sun Y, Chung E, Li Y, Wang A, de Leon M, Wisniewski T. 2011. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Neuroimage 55:1600-1609.
154. Yang X, Gondikas AP, Marinakos SM, Auffan M, Liu J, Hsu-Kim H, Meyer JN. 2012. Mechanism of silver nanoparticle toxicity is dependent on dissolved silver and surface coating in Caenorhabditis elegans. Environ Sci Technol 46:1119-1127.
155. Yang X, He C, Li J, Chen H, Ma Q, Sui X, Tian S, Ying M, Zhang Q, Luo Y, et al. 2014. Uptake of silica nanoparticles: Neurotoxicity and Alzheimer-like pathology in human SK-N-SH and mouse neuro2a neuroblastoma cells. Toxicol Lett 229:240-249.
156. Yin Y, Lin Q, Sun H, Chen D, Wu Q, Chen X, Li S. 2012. Cytotoxic effects of ZnO hierarchical architectures on RSC96 Schwann cells. Nanoscale Res Lett 7:439.
157. Yiu HH, Pickard MR, Olariu CI, Williams SR, Chari DM, Rosseinsky MJ. 2012. Fe3O4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: Development of a tool for neural cell transplantation therapies. Pharm Res 29:1328-1343.
158. 2 particles exert size and surface coating dependent retention and lesions on the murine brain. Toxicol Lett 207:73-81.
159. Zhang W, Phillips K, Wielgus AR, Liu J, Albertini A, Zucca FA, Faust R, Qian SY, Miller DS, Chignell CF, et al. 2011b. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: Implications for progression of Parkinson's disease. Neurotox Res 19:63-72.
160. Zhang XQ, Yin LH, Tang M, Pu YP. 2011c. ZnO, TiO(2), SiO(2, ) and Al(2)O(3) nanoparticles-induced toxic effects on human fetal lung fibroblasts. Biomed Environ Sci 24:661-669.
161. Zhao Y, Ye Y, Zhou X, Chen J, Jin Y, Hanson A, Zhao JX, Wu M. 2014. Photosensitive fluorescent dye contributes to phototoxicity and inflammatory responses of dye-doped silica NPs in cells and mice. Theranostics 4:445-459.
162. Zhou J, Fa H, Yin W, Zhang J, Hou C, Huo D, Zhang D, Zhang H. 2014. Synthesis of superparamagnetic iron oxide nanoparticles coated with a DDNP-carboxyl derivative for in vitro magnetic resonance imaging of Alzheimer's disease. Mater Sci Eng C Mater Biol Appl 37:348-355.
163. Ziemińska E, Stafiej A, Struzyńska L. 2014. The role of the glutamatergic NMDA receptor in nanosilver-evoked neurotoxicity in primary cultures of cerebellar granule cells. Toxicology 315:38-48.